BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 24330412)

  • 21. Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory.
    Lei P; Lei G; Tian J; Zhou Z; Zhao M; Wan C
    Int J Colorectal Dis; 2014 Oct; 29(10):1245-55. PubMed ID: 25080147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of health related quality of life in irritable bowel syndrome patients.
    Jamali R; Jamali A; Poorrahnama M; Omidi A; Jamali B; Moslemi N; Ansari R; Dolatshahi S; Ebrahimi Daryani N
    Health Qual Life Outcomes; 2012 Jan; 10():12. PubMed ID: 22284446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in patients with irritable bowel syndrome.
    Mönnikes H
    J Clin Gastroenterol; 2011 Aug; 45 Suppl():S98-101. PubMed ID: 21666428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials.
    Longstreth GF; Bolus R; Naliboff B; Chang L; Kulich KR; Carlsson J; Mayer EA; Naesdal J; Wiklund IK
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):411-20. PubMed ID: 15756093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring acceptance in irritable bowel syndrome: preliminary validation of an adapted scale and construct utility.
    Ferreira NB; Eugenicos MP; Morris PG; Gillanders DT
    Qual Life Res; 2013 Sep; 22(7):1761-6. PubMed ID: 23096496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.
    Gholamrezaei A; Zolfaghari B; Farajzadegan Z; Nemati K; Daghaghzadeh H; Tavakkoli H; Emami MH
    Acta Med Iran; 2011; 49(6):390-5. PubMed ID: 21874644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?
    Lackner JM; Gudleski GD; Zack MM; Katz LA; Powell C; Krasner S; Holmes E; Dorscheimer K
    Psychosom Med; 2006; 68(2):312-20. PubMed ID: 16554399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
    McLeod L; Ervin C; Fehnel SE; Eremenco S; Carson RT; Hanlon J; Coons SJ;
    Value Health; 2024 May; 27(5):614-622. PubMed ID: 38311181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.
    Coon CD; Hanlon J; Abel JL; Lundy JJ; Carson RT; Reasner DS
    Value Health; 2020 Mar; 23(3):362-369. PubMed ID: 32197732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype.
    Solem CT; Patel H; Mehta S; Mody R; Macahilig C; Gao X
    Curr Med Res Opin; 2016 May; 32(5):899-905. PubMed ID: 26836030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
    Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
    Shi H; Niu Y; Huang Q; Yang ZM; Yang L
    Zhongguo Zhen Jiu; 2021 Sep; 41(9):984-90. PubMed ID: 34491647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of the irritable bowel syndrome satisfaction with care scale.
    Dorn SD; Morris CB; Schneck SE; Hopper TM; Hu YJ; Kelapure R; Weinland SR; Norton WF; Norton NJ; Drossman DA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1065-71.e1-2. PubMed ID: 21854738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related symptom and life quality changes in women with irritable bowel syndrome.
    Tang YR; Yang WW; Liang ML; Xu XY; Wang MF; Lin L
    World J Gastroenterol; 2012 Dec; 18(48):7175-83. PubMed ID: 23326122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.
    Lee J; Lee EH; Moon SH
    Qual Life Res; 2016 Dec; 25(12):2985-2995. PubMed ID: 27686797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life.
    Si JM; Wang LJ; Chen SJ; Sun LM; Dai N
    World J Gastroenterol; 2004 Apr; 10(7):1059-64. PubMed ID: 15052694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.